Latest News
Thames River has confirmed that it plans to launch a global emerging markets absolute return fund on 1 June.
It seems everyone is scrambling to extend their service offerings ahead of July’s implementation of UCITS IV.
The latest industry report released by EFAMA shows that net inflows for UCITS in February were their highest since August last year.
Frankfurt-based asset manager, Lupus Alpha, is stepping up its plans to develop its benchmark-free absolute return strategies.
E Fund Management (HK), the Hong Kong arm of China’s second largest asset manager with USD29billion in AUM, plans to launch two new funds in 2011 according to CEO Cha
Atom Investment Co, a new Japan-focused hedge fund firm that only started trading less than a week after the devastating earthquake, was still able to gain 0.9 per cent in March re
Hong Kong-based Samena Asia Managers (SAM), the hedge fund seeding arm of Samena Capital, has entered into a joint venture with Geneva-headquartered Reyl &
Online& has launched its tiered website platform designed specifically to assist companies in the alternative investment community enhance their marketing, investor relations, regulatory compliance, and data security efforts. With flexible pricing and no ongoing subscription costs, the solution scales to provide the right tools for any size firm.
The modular, scalable system robustly supports marketing, investor relations, compliance, and security requirements for investment management firms and service providers.
Developed and refined over the course of the past decade, the Online& Investment Management components have been deployed for large established hedge fund organisations, small start-up managers, CTAs, funds of funds, and
The Securities and Exchange Commission has charged a former hedge fund portfolio manager with insider trading in a bio-pharmaceutical company based on confidential information about negative results of the company’s clinical drug trial.
The SEC alleges that Dr Joseph F “Chip” Skowron, a former portfolio manager for six health care-related hedge funds affiliated with FrontPoint Partners LLC, sold hedge fund holdings of Human Genome Sciences Inc (HGSI) based on a tip he received unlawfully from a medical researcher overseeing the drug trial. HGSI’s stock fell 44 per cent after it publicly announced negative results from the trial of Albumin Interferon
Following confirmation of the AIFM Directive at the end of 2010, Jersey has announced that it is working to deliver a range of flexible options, including a fully AIFMD compliant regime and to retain existing complementary regimes for asset managers that have no wish to access EU institutional capital under an AIFMD passport.
The island has taken a joined up approach to AIFMD, with commercial representatives of its funds industry working in partnership with Jersey Finance, the central promotional body for the international finance centre, to ensure that Jersey’s strategy offers certainty for existing managers and a highly competitive
